open access

Vol 4, No 4 (2003): Practical Diabetology
Original articles (submitted)
Published online: 2003-09-18
Get Citation

Effects of treatment with HM insulin produced by Bioton, NovoNordisk and Eli Lilly in children with type 1 diabetes diagnosed in 2001 and 2002

Anna Noczyńska, Renata Wąsikowa
Diabetologia Praktyczna 2003;4(4):295-298.

open access

Vol 4, No 4 (2003): Practical Diabetology
Original articles (submitted)
Published online: 2003-09-18

Abstract

INTRODUCTION. The aim of the study was the appreciation of the degree of metabolic control in children treated with Bioton, Novo Nordisk or Eli Lilly insulin.
MATERIAL AND METHODS. Examined were 142 children with type 1 diabetes treated in the years 2001 and 2002, aged 2–18 years (mean 11,5 years). Analyzed were age, duration of the diabetes therapy, frequency of acute complications, HbA1c.
RESULTS. The mean levels of HbA1c were in the group 1 - 7,28%, group 2 - 6,58%, group 3 - 7,64%. In the investigated children severe hypoglycemia was not observed. Only in the group of 6 youngest children (< 5 years of age) in the course of acute infections observed were metabolic ketosis. In all the children observed was a decrease of insulin requirement but in none of them a complete remission.
CONCLUSION. The treatment with insulin Bioton, Novo Nordisk and Eli Lilly restored a good metabolic control in patients with type 1 diabetes. Patients treated with an intensive insulin therapy with a pen for an optimalisation of the metabolic control should receive an intermediate insulin at least in two daily doses.

Abstract

INTRODUCTION. The aim of the study was the appreciation of the degree of metabolic control in children treated with Bioton, Novo Nordisk or Eli Lilly insulin.
MATERIAL AND METHODS. Examined were 142 children with type 1 diabetes treated in the years 2001 and 2002, aged 2–18 years (mean 11,5 years). Analyzed were age, duration of the diabetes therapy, frequency of acute complications, HbA1c.
RESULTS. The mean levels of HbA1c were in the group 1 - 7,28%, group 2 - 6,58%, group 3 - 7,64%. In the investigated children severe hypoglycemia was not observed. Only in the group of 6 youngest children (< 5 years of age) in the course of acute infections observed were metabolic ketosis. In all the children observed was a decrease of insulin requirement but in none of them a complete remission.
CONCLUSION. The treatment with insulin Bioton, Novo Nordisk and Eli Lilly restored a good metabolic control in patients with type 1 diabetes. Patients treated with an intensive insulin therapy with a pen for an optimalisation of the metabolic control should receive an intermediate insulin at least in two daily doses.
Get Citation

Keywords

diabetes type 1; insulin therapy; metabolic control

About this article
Title

Effects of treatment with HM insulin produced by Bioton, NovoNordisk and Eli Lilly in children with type 1 diabetes diagnosed in 2001 and 2002

Journal

Clinical Diabetology

Issue

Vol 4, No 4 (2003): Practical Diabetology

Pages

295-298

Published online

2003-09-18

Bibliographic record

Diabetologia Praktyczna 2003;4(4):295-298.

Keywords

diabetes type 1
insulin therapy
metabolic control

Authors

Anna Noczyńska
Renata Wąsikowa

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl